Before a panel of lawmakers, lobbyists for hospitals, doctors, and insurance companies justified consolidation in their markets while blaming others for stifling competition.
A U.S. House subcommittee heard payers and providers offer their views on competition and consolidation of the healthcare marketplace under the Patient Protection and Affordable Care Act Thursday.
For the most part, lobbyists for hospitals, doctors, and insurance companies spent their morning before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law defending their turf, trumpeting cost-savings innovations by their members, and justifying consolidations in their markets while blaming others for stifling competition.
Barbara L. McAneny, MD
American Medical Association board member Barbara L. McAneny, MD, told the subcommittee that the federal government should more closely examine consolidations in the health insurance and hospital sectors.
"Given the present structure of the health insurance market, health insurers have the ability unilaterally or through coordinated interaction to exercise market power by raising premiums, reducing service, or stifling innovation," McAneny said. "Accordingly, health insurer markets require more, not less, competition and mergers must be carefully scrutinized."
McAneny said that many hospital markets already are highly concentrated and non-competitive and that further acquisition could "undermine the ability of physicians on behalf of patients to shop for hospitals based upon quality factors."
"Too much consolidation reduces the incentive of hospitals to compete on these factors, allowing the merged hospital in a concentrated market to provide potentially sub-optimal care for patients," she told the committee.
"A hospital acquiring market power through merger may also substantially lessen the practice options open to physicians such that the hospital obtains market power as an acquirer of physician services."
Rick Pollack, president and CEO of the American Hospital Association, told the subcommittee that hospitals are adapting to a rapidly changing landscape that is moving toward value-based care and reimbursement models.
"To better serve their communities, hospitals and health systems are integrating with other providers in a variety of ways to ensure more coordinated and patient-centered care and improve efficiency and reduce costs," Pollack said.
"Hospitals are making progress in all of these areas despite operating in an environment that has enormous capital and regulatory demands and payments linked increasingly to achieving high performance. Meeting these demands often requires significant restructuring for hospitals, all of which has taken place during a period of historically low levels of hospital price growth."
"On the other hand," Pollack said, "the recently announced commercial insurance deals will not benefit consumers. Instead, they will lead to further consolidation of an already highly concentrated health insurance market, fewer choices for consumers for commercial insurance and MA plans, and higher premiums and/or out-of-pocket costs."
Rick Pollack
AHIP's Stance
Not surprisingly, Dan Durham, executive vice president, strategic initiatives, at America's Health Insurance Plans, did not agree with Pollack's assessment.
"Provider-related costs are a significant portion of total medical costs, and the growth in such costs has had a critical, and detrimental, effect on consumers," Durham said. "Consumers benefit when healthcare providers compete to offer them lower costs, higher quality services, and innovative approaches to delivering care."
"There are situations in which provider consolidation does not impede these benefits or may even enhance them. In other situations, however, consolidation diminishes competition among providers and leaves consumers with higher costs, diminished quality, and a reduced prospect of innovation or improvement."
Thursday's testimony was heard before a subcommittee thick with partisan acrimony.
Subcommittee Chairman Tom Marino, (R-PA), who has voted repeatedly to repeal Obamacare, said that Thursday's hearing was the first in a series that would examine PPACA's effect on competition and cost in the healthcare marketplace. He made his position clear before testimony was heard.
"There is no doubt that there has been significant movement in each of the hospital, insurer, and physician markets since the enactment of Obamacare," Marino said in opening remarks. "I have infinitely more confidence in the judgment of a competitive marketplace over the judgment of government. Obamacare is another government experiment of attempting to replace the will of the market with its own, an experiment that in my view has gone horribly wrong."
Subcommittee ranking member Hank Johnson, (D-GA), said in his opening statements that the PPACA has expanded coverage to 16.4 million uninsured people, dropping the uninsured rate by 35% while lowering the cost of care. He stated that consolidation in the healthcare sector had been well underway before PPACA went into effect.
"It's clear that now we have put it to work, the Affordable Care Act is saving lives and money," Johnson said. "Rather than demonizing an administration that has done so much for so many, we should be ensuring that the progress we've made in such a short time is not jeopardized by anti-competitive behavior or consolidation."
As diabetes rates ratchet steadily up, researchers find that the use of community health workers and peer support groups for chronic disease prevention and management can work in all settings, particularly low-resource areas.
A grim new report out this week estimates that half of Asian Americans and Hispanic Americans with diabetes don't know they have the disease.
The estimates from the National Institutes of Health and the Centers for Disease Control and Prevention are detailed in the Sept. 8 issue of the Journal of the American Medical Association and the findings should alarm anyone who cares about population health.
The estimates for the first time quantify the prevalence of diabetes in Asian Americans and the news is not good. Researchers estimate that Asian Americans have the highest proportion (51%) of undiagnosed diabetes among all ethnic and racial groups. Hispanic Americans have the highest prevalence (23%) of diabetes, 49% of which is undiagnosed.
But wait. It gets worse.
The NIH/CDC researchers estimate that the prevalence of diabetes for all US adults went up by as much as 12% from 1988 to 2012. Those levels rose regardless of sex, age, level of education, income, or racial group or ethnic subgroup.
Thomas Gaziano, MD
About 14% of the overall population has diabetes, of which just over 5% is undiagnosed. About 20% of non-Hispanic black adults have diabetes, with about 37% undiagnosed. Prevalence of diabetes for non-Hispanic whites is 11%, and 32% are undiagnosed. Diabetes cost the nation about $245 billion in 2012 in the form of medical care and lost productivity.
The only ray of sunshine to come out of the estimates is that the proportion of people with undiagnosed diabetes dropped 23% over that same nearly three decades.
Coincidentally, these estimates arrived in my email this morning as I was listening to a three-hour briefing sponsored by Health Affairs entitled: Noncommunicable Diseases: The Growing Burden.
I'll focus on a briefing in Health Affairs detailing the success of community-based interventions that was given by Thomas Gaziano, MD. He determined that marginally trained community health workers in resource-poor countries such as South Africa, Mexico, and Guatemala could provide effective screenings for cardiovascular diseases in adults, by asking a few simple questions using either a paper-based or cell phone-based screening tool.
"We found that screening by community health workers was very cost-effective or even cost-saving in all three countries, compared to the usual clinic-based screening," Gaziano wrote. "The mobile application emerged as the most cost-effective strategy because it could save more lives than the paper tool at minimal extra cost."
A briefing by Edwin B. Fisher, PhD, focused on the use of community health workers and peer support groups for chronic disease prevention and management. The good news here is that these programs can work in all settings, particularly low-resource areas.
"Success factors for peer support programs include proactive implementation, attention to participants' emotions, and ongoing supervision," Fisher wrote. "Reaching those whom conventional clinical and preventive services too often fail to reach; reaching whole populations, such as people with diabetes, rather than selected samples; and addressing behavioral health are strengths of peer support that can help achieve healthcare that is efficient and of high quality."
Fisher cited seven community health workers in Chicago who were able to reach 3,787 "hardly reached" low-income Latino adults to help them monitor blood sugar levels.
"A big issue in healthcare around the world, especially with non-communicable diseases, is the hardly reached, those who we too often fail to engage," Fisher said at the briefing. "We found that peer support is remarkable effective."
Given that a frighteningly large percentage of Americans in general and minorities in particular don't know they have diabetes, rallying communities around improving population health seems an obvious tactic. Yet, Fisher says other countries with far fewer resources, such as Thailand and Pakistan, have done a much better job.
"The U.S. is sort of culturally handicapped in approaching these kinds of interventions," Fisher says. "In this area we very much have more to learn from places like Pakistan and Thailand as opposed to their needing to learn from us."
Federal prosecutors allege that between 2003 and 2013, Columbus Regional Healthcare System "provided excessive salary and directorship payments to an oncologist affiliated with the hospital in a financial arrangement that violated the Stark Law."
A Georgia hospital will have to pay upwards of $35 million to resolve allegations of False Claims Act violations involving self-referrals and overcharging for care, federal prosecutors say.
Columbus Regional Healthcare System has agreed to pay $25 million, plus additional contingent payments not to exceed $10 million, for a maximum settlement amount of $35 million. Andrew Pippas, MD, a Columbus-based hematologist/oncologist affiliated with the hospital, has agreed to pay $425,000 for his alleged role in the infractions, according to Michael Moore, U.S. Attorney for the Middle District of Georgia.
Federal prosecutors allege that between 2003 and 2013, Columbus Regional "provided excessive salary and directorship payments to Pippas that violated the Stark Law," which prohibits certain physician referrals for Medicare and Medicaid patients if the physician and the referring entity have a financial relationship.
Prosecutors also allege that from May 2006 through May 2013, Columbus Regional overbilled Medicare and Medicaid for services at higher levels than supported by the documentation, and between 2010 and 2012, they overbilled for radiation therapy at higher levels than the therapy that was provided.
Columbus Regional and Pippas will pay $24.6 million to the federal government for federal healthcare program losses and $759,000 to the state of Georgia for the state share of its Medicaid losses.
"Now that we have these matters behind us, I am looking forward with renewed energy to continuing to advance and improve the cancer care we deliver at the John B. Amos Cancer Center," said Pippas, in a statement issued by Columbus Regional. As of Tuesday evening, Pippas was listed on the leadership page of the Georgia Society of Clinical Oncology.
"The maximum amount of this settlement, some $35 million, is appropriate given the number of alleged violations involving the False Claims Act and the Stark Act," Moore said in prepared remarks.
"Access to healthcare is on everyone's mind, especially with respect to rural communities. The type of conduct alleged in this case puts that access at risk," Moore said. "This settlement reflects on the one hand, the Department of Justice's commitment to make sure that hospitals and physicians who commit violations of federal law are held to account, and on the other hand, especially with the requirement of the monitoring agreement, makes sure that we continue to have appropriately functioning healthcare providers accessible to the wide array of communities they serve."
'Not an Admission of Liability'
Columbus Regional issued a statement announcing the $35 million settlement, but noted that it "is not an admission of liability. The parties agreed to settle in order to avoid continued costly and protracted litigation."
"We are glad to put these issues behind us and focus 100% of our energies on continuing to deliver quality patient care and service at all of our entities," Columbus Regional CEO and President Scott Hill said in a statement released by his office.
Columbus Regional will enter into a five-year corporate integrity agreement with the Department of Health and Human Services, Office of the Inspector General.
The settlements resolve allegations filed in two lawsuits by Richard Barker, a former Columbus Regional executive. The lawsuits were filed under the whistleblowerprovisions of the False Claims Act and the Georgia False Medicaid Claims Act. Barker's share of the settlement has not yet been determined.
Since January 2009, the Justice Department has recovered a total of more than $24.9 billion through False Claims Act cases, with more than $15.9 billion of that amount recovered in cases involving fraud against federal healthcare programs, prosecutors said.
Nearly one in four of the 173,000 new jobs created in the U.S. economy in August was in healthcare, according to preliminary figures from the Bureau of Labor Statics.
Preliminary jobs data from the Bureau of Labor Statics shows that healthcare created 41,000 jobs in August, 314,200 jobs in the first eight months of 2015 and 457,000 new jobs over the past 12 months. The healthcare sector has accounted for 18.5% of the nearly 1.7 million non-farm payroll additions in the overall economy in 2015, BLS preliminary data show.
Within the healthcare sector BLS data show that the ambulatory healthcare services created 21,000 new jobs, and hospitals created 16,000 new jobs. Nursing and residential care created 3,500 jobs.
The healthcare sector accounted for more than 15.1 million of the nation's jobs in August, with more than 4.9 million jobs at hospitals, more than 6.9 million jobs in ambulatory services, and more than 3.3 million people in nursing and residential care, BLS preliminary data show.
BLS data from July and August are preliminary and may be considerably revised in the coming months.
In the larger economy, the 173,000 nonfarm payroll additions in August tapped down the nation's unemployment rate to 5.1%, with 8 million people unemployed.
The number of people unemployed for less than five weeks fell by 393,000 in August. The number of long-term unemployed—people jobless for 27 weeks or longer—was 2.2 million in August, and represented 27.7% of the unemployed, BLS preliminary data show.
Announcements of separate joint ventures between Lifepoint and a regional medical center in Wisconsin and Carondelet and three major health systems in Arizona top the latest round of healthcare business news.
LifePoint Health has entered the Wisconsin hospital market after finalizing a joint venture that gives the Brentwood, TN-based for-profit company a majority stake in Watertown Regional Medical Center, the hospitals announced jointly on Tuesday.
Jeff Seraphine
The deal marks the first conversion of a hospital's tax status from not-for-profit to for-profit in the state of Wisconsin.
Jeff Seraphine, president, Eastern Group at LifePoint Health, says the hospital chain has had Wisconsin on the expansion radar for a long time.
"It's always been an attractive state for us, there just hasn't been a lot of opportunities," Seraphine says. "There haven't been a lot of pieces moving around up there that gave us the opportunity to partner with communities, but when the Watertown opportunity came about, we were right there and excited to be a part of it."
Jeff Baum, chairman of the WRMC board of directors, says it took a little extra effort to convince community leaders and state regulators, that the conversion to for-profit status would benefit all of the stakeholders.
"We had a lot of explaining to do. The staff got it pretty quickly, but it did raise some questions. Let's put it that way," Baum says. "When the community heard we were going to become a for-profit hospital the first thing they said was, 'Oh my God! You're going to have to raise all the prices to pay the shareholders.' But that's not true."
Allan Baumgarten, a Minneapolis-based research consultant who monitors hospital acquisitions across the Midwest, says Wisconsin has been "relatively late to get for-profit hospital companies."
"Michigan didn't have a for-profit hospital presence until about six years ago, but now has Tenet, LifePoint, and Prime and almost got Community Health Systems," Baumgarten says. "I assume that LifePoint is looking for other hospitals to acquire in the state."
"Almost all of the hospitals in the southeast corner of the state (from Madison south and east to the lake and the Illinois border) are already in larger systems," he says. "If LifePoint wants to grow in that region, it may be looking at some of those systems. Or it may be looking in other parts of the state, where there are still a few dozen independent hospitals, many of them small critical access hospitals."
Financial terms of the JV were not immediately disclosed, however it is understood that LifePoint will own 80% of the hospital and WRMC and the community will own 20%. Governance will be shared equally on a board with equal representation from WRMC and LifePoint.
The joint venture will invest $100 million in WRMC and the community over the next 10 years, targeting "significant advancements" in technology, expanding clinical services and population health and wellness initiatives. No layoffs are anticipated and LifePoint has committed to hiring all employees, subject to pre-employment screenings.
Seraphine says LifePoint was comfortable with an 80/20 joint venture model instead of an outright acquisition because WRMC wanted an ownership stake, and that similar governing structures have worked in other LifePoint ventures.
"Our goals and the way we work in either a full acquisition or a partnership model [is] so we work with the community to find out what works for them," Seraphine says. "We feel comfortable with a shared governance model where we can work in a collaborative way with the community, especially in a state like Wisconsin where there hasn't been a long history for an investor-owned company like LifePoint. It's a great way for the community to be at the table from a governance perspective, and it allows people to be more comfortable with a new arrangement."
Baum says the JV ensures that the community will have a say in how healthcare is delivered.
"We still own a part of the hospital and that made it much easier to talk to the man on the street and explain that we still owned part of the hospital," he says. "When LifePoint offered up 50% of the board, that pretty much sewed it up for us."
Proceeds from the transaction will be used to pay off WRMC's existing financial obligations. The remaining assets will be used to create a charitable foundation focused on community health.
Richard Keddington will become WRMC's new CEO on Sept. 14, replacing John Kosanovich, who retires after 20 years as WRMC's CEO. Keddington has served for the past five years as CEO of Select Specialty Hospital, a two-campus, 63-bed hospital in Milwaukee.
The joint venture between Watertown Regional Medical Center and LifePoint was subject to regulatory reviews by the Attorney General of Wisconsin. Baumgarten says the JV with LifePoint could signal an end to WRMC's strategic alliance with University of Wisconsin Health. "The website no longer mentions anything about being a member of the UW Health Partnership."
Financial terms of the deal were not disclosed, and the health systems declined to comment beyond the media release. However, Tenet is the majority partner and will manage the operations of the network's three hospitals, two physician groups, outpatient and ambulatory services, and affiliated businesses in Tucson and Nogales, AZ. Dignity Health and Ascension have minority interests in the partnership, the health systems said in a joint statement.
Tenet and Dignity Health separately own and operate hospitals and clinics in the Phoenix area and together manage Arizona Care Network, an accountable care organization that includes more than 750 facilities across Tenet's and Dignity Health's Phoenix-based healthcare systems, with more than 3,400 providers and more than 200,000 covered lives.
The Tucson-based joint venture will connect Carondelet to ACN, which will is expected to increase access to care for patients, strengthen and grow Carondelet's relationships with physicians, provide development opportunities for current and future employees, and fund strategic growth initiatives across Southern Arizona.
The facilities in the new partnership include:
St. Joseph's Hospital (486 beds) in Tucson
St. Mary's Hospital (400 beds) in Tucson
Holy Cross Hospital (25 beds) in Nogales
Carondelet Heart & Vascular Institute at St. Mary's Hospital
Carondelet Neurological Institute at St. Joseph's Hospital
Carondelet Medical Group
Carondelet Specialist Group
Carondelet's services also include imaging centers and other ambulatory services and ancillary businesses. The joint venture will maintain Carondelet's Roman Catholic identity through an agreement with the Diocese of Tucson. Carondelet's existing charity care policies will remain in place.
SSM Health Commits $500M to Build New St. Louis Hospital
One day after transferring ownership from Tenet Healthcare Corp., Catholic, not-for-profit SSM Health announced on Tuesday that it has committed $500 million to build a new replacement hospital and outpatient care center within the next five years. The new hospital will be built near the existing 365-bed academic medical center now known as SSM Health St. Louis University Hospital, the health system said in a media release.
SSM Health and Saint Louis University this week mark the start of their expanded partnership, which includes Saint Louis University Hospital joining SSM Health St. Louis. In June, SLU announced it would reacquire the hospital from Tenet and would give the hospital to SSM Health in exchange for a minority financial interest and governance rights in SSM Health St. Louis. The deal became official on Tuesday.
"While the current hospital has served the community well, we have the opportunity to construct state-of-the-art academic facilities that incorporate the best practices in patient-centered design," said SSM Health President/CEO William P. Thompson said in prepared remarks. "This significant investment will enable us to deliver an improved patient experience and even better care for our community."
For-profit Tenet has operated SSM Health St. Louis University Hospital for the past 17 years. The sale was completed on Monday. The relationship between SSM Heath and the university extends back to 1903.
Not-for-profit hospitals have emerged from the recession as leaner and better-managed organizations poised to take advantage of an improving economy, says a Moody's Investors Service analyst.
The financial outlook for not-for-profit hospitals has been revised from "negative" to "stable" by Moody's Investors Service, the bond rating agency's first upgrade for the sector since 2008.
"The outlook revision represents significant gains in the number of people with insurance, growing patient volumes and sizeable reductions in bad debt that are contributing to very strong growth in operating cash flow," Moody's said in its analysis.
"The stable outlook expresses our view that fundamental business, financial, and economic conditions for the not-for-profit and public healthcare sector will neither erode significantly nor improve materially over the next 12 to 18 months."
After two years of flat cash growth, Moody's survey of about 200 not-for-profit hospitals saw operating cash flow growth spike to 12.3% in 2014, up from 0.3% in 2013. Through March of this year, cash flow growth stands at 11.5%. However, that growth is expected to taper off through 2016.
In addition, bad debt was down about 15% in Medicaid expansion states, and down about 4% in non-expansion states.
Daniel Steingart, an analyst and senior vice president at Moody's, says not-for-profit hospitals have emerged from the recession as leaner and better-managed organizations that are poised to take advantage of an improving economy.
"Just as there had been perfect storms over the past several years that had conspired to keep cash flow growth down and to keep overall performance lower than it had been and declining over previous years, you are seeing a bounce back," Steingart says.
"It's a strong performance that we are in the midst of. Some is the generally improving conditions and some of it is the reversion to the mean after some very poor years."
"You have volume growth picking up because of deferred care, and gains in insurance coverage—a portion of which is the economy, a portion of which is Obamacare—and then you also had at the latter end of last year continuing into 2015 some real pick up in overall volumes, not just this pent up demand."
While the Patient Protection and Affordable Care Act was a factor in the not-for-profit hospital sector upgrade, Steinhart says he "would not pin it all on Obamacare."
"If it were simply that, you would see a much bigger difference between the Medicaid expansions and non-expansion states. The reality is everyone has improved," he says. "Yes, there were health insurance exchanges in Texas and Florida and more people gained coverage in those states, but the biggest gains were in Medicaid populations and that didn't happen in those states. I'm not saying Obamacare had no impact. It clearly did. Bad debt coming down has had a positive impact. But it is not the entire story."
Steingart says that the outlook could upgrade to "positive" if the operating environment improves and allows for stronger cash flow. If cash flow is below medical inflation, however, the outlook could be downgraded to "negative."
Either way, Steingart says hospitals should not expect that the level of volume growth they are now seeing will continue.
"It is not a return to the go-go years of the early 2000s," he says.
He says hospitals will also have to contend with rising labor costs.
"A lot of hospitals have been keeping the belt very tight," he says. "Even though there have been a lot of job gains in the sector, a lot of hospitals are telling us they are holding tight on salary and benefits. Wage pressure is going to be an issue over the next six months or so."
Beyond the 18-month forecasting window, Steingart says not-for-profit hospitals face potential bottom-line challenges in the movement toward population health and value-based care that are expected to reduce in-patient days. In addition, information technology upgrades, strategic investments in physician practices, and the growing shift of coverage toward Medicare as the population ages, also will squeeze bottom lines.
Data collected from the nation's 1,300 federally qualified community health centers shows a significant rise in the number of health center patients who are covered by health insurance.
Data compiled from the first year of the Patient Protection and Affordable Care Act is starting to trickle out and it's burnishing the legacy of federally qualified community health centers as a focal point for access to healthcare in poor and underserved areas.
According to the 2014 Uniform Data System, which collects patient and healthcare information from the nation's 1,300 FQHCs, the number of health center patients with health insurance rose by more than 2.3 million, a 17% increase, while the number of uninsured patients declined by 1.2 million, a 16% decrease.
Peter Shin
The total number of patients served rose by more than 1.1 million, a 5% increase. Since 1996, the total number of patients served at federally funded health centers has nearly tripled, from slightly more than 8 million to almost 22.9 million patients served by 2014.
The findings were compiled in a report from the Geiger Gibson/RCHN Community Health Foundation Research Collaborative. The director of the collaborative and a coauthor of the report, Peter Shin, says the data provides a "first glimpse" of how health centers are impacting access in the first full year of federal health reform in 2013.
"If anything, it continues to show that these are very strong programs that are very effective in reaching out to low income populations," he says. "They are in these federally designated underserved communities, reaching the population that they are mandated to reach."
Shin says the data reflects both Medicaid expansion states and the 20 states that have declined to expand Medicaid. He says the collaborative will work in the coming weeks to flesh out the differences.
'A No-Brainer'
"We are just getting into the data now to look at some of the comparative numbers between the two groups," he says. "I don't have anything to show you, but we are expecting that the numbers will be considerably higher among the insured population for the expansion states versus the non-expansion states. That is a no-brainer."
Obviously, the major growth in insurance coverage can be credited to the PPACA's Medicaid expansion. Because patients at health centers tend to be poor, Medicaid accounted for 79% (1.8 million people) of the 2.3 million increase in insured patients served by health centers. The number of privately insured health center patients also rose from 3.1 million to 3.6 million, an increase of 16% and by far the greatest increase in private insurance coverage over the 1996 to 2014 time period, according to the UDS data.
"I don't want to gloss over the fact that there were also significant efforts from health centers doing outreach and enrollment for the patient populations," Shin says. "Health centers helped 10 million people get coverage in one way or another, whether it was through the health centers or through another provider. Regardless, health centers did a tremendous job. [They] are going to try to make sure patients are connected as much as possible and find a medical home as much as possible. That is one piece of the story that has helped, particularly for getting patients more educated and aware of the coverage options they may have."
Shin says it's too early to determine if the PPACA and near-universal coverage has changed the patient mix at FQHCs on a national level.
"For that we'd have to look at the Massachusetts experience," Shin says. "They only have about a 3% uninsured rate and we are finding that their health centers are still not only a provider of choice for the insured population, but they are still key safety net providers for the uninsured and now serve about one-in-two uninsured in Massachusetts, which is about double what it was before health reform up there."
Shin says he expects those story lines to vary among Medicaid expansion states as the PPACA rollout continues to change the coverage landscape.
'A Significant Economic Boost'
"Obviously it will be more or less the status quo for non-expansion states," he says. "In expansion states we are going to find a tremendous boost in access, which will impact disparities in heath and which will impact local economies as well. We are going to see a lot of this play out over the long run as a real major advantage coupling not only Medicaid expansion but these investments in health centers. That is going to be tremendous boost for the local economies."
While the collaborative report does not address the economic impact of the Medicaid expansion, Shin says the community benefit is apparent.
"It is an $18 billion program, and we are just talking about expenditures," he says. "That is going back to the communities and reflects some of the new jobs, because obviously they have hired new people. We are talking about a significant economic boost or a lot of these economically disenfranchised communities."
"People forget there were also significant investments in health centers under the ARRA (American Recovery and Reinvestment Act), where they were trying to create more jobs in health centers and did just that," Shin says. "They were reaching out to the people who normally would not be afforded that opportunity. Health centers are trying to affect not only the daily lives of the population but also providing some opportunities. A lot of the hires are from the communities. A lot of doctors who have been trained in underserved communities come back."
Shin says the UDS data prompts follow up questions, and the collaborative will spend the next few months looking for answers.
"We will look at access issues to see if health centers might have the appropriate staffing levels given that they have significant recruiting and retention challenges in these isolated communities," he says.
"We are going to look at impact on quality, the changes that are affected by having patients who are now newly converted to being insured; to what extent they are seeing sicker patients or might be able to move the dial on making the general patient population a lot healthier. We have quite a few things to look at in terms of operations, performance, quality of care, financial and economic impact. We will look at all of these sectors. We will be able to tell a lot from this data."
Based on annual median wages reported by the Bureau of Labor Statistics, surgeons earn the highest annual median wage, followed by psychiatrists and primary care physicians.
Despite reports of job dissatisfaction, surgeons, psychiatrists and physicians are the three highest-paid professions in the United States, according to the CareerCast's 2015 list of Top 10 best paying jobs.
Using annual median wages reported by the Bureau of Labor Statistics, CareerCast found that surgeons topped the list with an "annual median wage" of $352,220, followed by psychiatrists at $181,000, and primary care physicians at $180,180. All three of the medical disciplines were expected to see a wage "growth outlook" of 18% through 2022, according to CareerCast, a niche job search portal based in Carlsbad, CA.
Healthcare professions presented six of the 10 highest paying jobs on the list. Dentists came in at No. 5, with a median annual wage of $146,340 and a growth outlook of 16%; orthodontists were No. 7 with an annual wage of $129,110 and a growth outlook of 16%; and pharmacists were No. 10, with an annual wage of $121,000 and a growth outlook of 14%, according to CareerCast.
Physicians defend their high compensation by noting that they spend up to 10 years in training and that they accrue huge student loan debts that can take decades to pay off. The Association of American Medical Colleges reports that the median debt was $180,000 for medical students graduating in 2014.
While the specific value of compensation paid to various professions can vary from survey to survey, the findings by CareerCast are consistent with lists compiled by other sources. For example, Forbes magazine listed "physician" in general as the "highest paying in-demand job" in 2015, with an "average base salary" of $212,000. Pharmacy manager was No. 2 on the Forbes list with an average base salary of $131,000.
Healthcare professions represent seven of the top ten "100 Best Jobs"as rated by U.S. News & World Report, and Money magazine. Their ranking take in other factors such as quality of life, challenging but not overly stressful, career advancement, and hiring demand.
Although limited to healthcare professions, one of the more detailed assessments of physician compensation comes from the annual physician recruiting search results published by Merritt Hawkins, the Irving, TX-based physician recruiters. Invasive cardiologists topped the Merritt Hawkins list of Top 10 in most demand specialties with an annual income of $525,000.
The problem with precision medicine is "the paradox of prevention… some very significant achievements at the individual level can be achieved without having much of an impact at a population level," says a public health researcher.
So far, precision medicine has been long on potential but short on delivery and some health policy experts question whether this focus on this novel and cutting edge medical discipline may distract from proven but more mundane population health strategies.
In a recent essay in the New England Journal of Medicine, Ronald Bayer, and Sandro Galea, MD, write that the movement toward precision medicine comes even as consensus solidifies around the idea that health differences between and within groups have more to do with social factors than with clinical care.
Ronald Bayer
Bayer shared his concerns about the potential drawbacks of precision medicine in an interview with HealthLeaders Media. The following is an edited transcript.
HLM: What do you mean by "precision medicine?"
Bayer: "There is a view that the goal of public policy and science should be to make diagnoses and focus treatments that are specific to the individual, so that rather than thinking about how we should treat large numbers of people, we should be concerned with which people will be most likely to respond to a given intervention or therapy because of their biological or genetic background.
We believe that precision or personalized medicine takes our focus off the question of 'what do we do to improve the health of vast numbers of people living globally' and asks a different question, which is 'how can we target medicine most effectively to treat those who are sick?' We think this is a huge mistake.
HLM: Why?
Bayer: It is focusing on the wrong problem because we have just begun to provide decent and adequate healthcare for all of our citizens under the Accountable Care Act and we have a long way to go to just provide decent medical care to people.
The issue goes even beyond that. Americans don't know it, but they are at the bottom of the heap when we talk about life expectancy and every other stage of the life cycle when compared with other people in other countries similarly situated. The question is why and the answer can't be that they know better what the genome of their citizens is, or that they know better how to target medical care.
The reason clearly is that the US has become over the last 40 years increasingly and strikingly vastly socially unequal. Everything we know about who gets sick, how they fare when they get sick, who dies, when they die, at a population level, is that social inequality is bad for health.
HLM: How is a focus on precision medicine detrimental to population health?
Bayer: For example, the question we want to ask about tobacco is 'why do some people smoke for a lifetime and never get cancer or emphysema?' My question is why 'do so many people who smoke get sick?' The answer from a public health point of view is to severely regulate tobacco consumption, not to figure out the genomic bases for figuring out lung cancer or heart disease.
In public health it is call the 'paradox of prevention.' Very small reductions in risk at the individual level can produce huge consequences at a population level. The problem with precision medicine is that some very significant achievements at the individual level can be achieved without having much of an impact at a population level. That is what we have to be concerned about."
HLM: Do you see any value in precision medicine?
Bayer: Yes. I believe we should push the frontiers of science and there is much we may learn in the future. My sense as I read the literature is that there is a lot of hype involved. While a lot of serious scientists may understand the limits of what they are doing, the way it is presented to the public is that this is going to transform our world not in the next century but within our experience. I just think that is baloney.
Advancing the frontiers of science is a great idea. It's a question of priorities and a question of the public discourse about health. Every time I read a statement that advances the agenda of personalized medicine, it has the aura of religious fervor and that is misleading. And from the point of view of public health, we know that there are these vast disparities within our own nation.
Americans like to boast that we have the most technologically sophisticated healthcare system in the world and they go from that to say which of course means we must be the healthiest people.
There is no connection between the two, and at some level the question is, 'what is the metric you use to define the best healthcare system in the world?' Is it the one that can take care of a rare disease most exquisitely or is it the one that has an impact on life expectancy?
HLM: Why do you think precision medicine is getting so much attention?
Bayer: Being at the leading edge of science and exploring new frontiers accounts for it. My concern is that what we've written might be seen as 'anti science.' People at the center of precision medicine have said we are cranking out the same old story, but I think there is a need for a serious conversation, where people take a step back, take a deep breath, stop hyper-ventilating and ask 'what are our needs?' How do we prioritize our resources and our attention. It is pretty clear that the precision medicine crowd is diverting our attention from where it needs to be.
HLM: Do you get a sense that precision medicine is somehow designed with more affluent patients in mind?
Bayer: More money is spent on the treatment for male pattern baldness globally than on research on tuberculosis. There are hardly any new drugs in the pipeline for TB, which kills about 2 million people a year. The drug companies aren't interested because it doesn't look like these drugs will have huge profit margins. The use of the words 'personalized' and 'precision' is strategically very interesting.
Of course we want clinical intervention to be as precisely targeted to the problem as possible and certainly we want our doctors to treat us as people and not statistics. But it sometimes seems to be something darker that is involved, and that is, a kind of mismatch between what public and population health tells us we need to be doing and this huge intellectual and resource investment in the world that is not going to make an impact on those issues.
HLM: You cite $215 million that NIH has earmarked for precision medicine research. That's not a lot of money when you consider that the U.S. spends close to $3 trillion on healthcare.
Bayer: The goal and mission of the NIH is to advance the frontiers of medicine and science. The absolute spending at this point may look small, but when NIH says the 21st century is the century of biology, I'm concerned about the sharpness of the challenge.
It's time for those who've been proclaiming the vast implications for wellbeing from precision medicine to give an explanation for why a focus on precision medicine is not a diversion from meeting the health needs of Americans at a global level, the vast numbers of people who suffer and die too early from preventable diseases.
HLM: How can we strike a balance?
Bayer: There is much we might learn delving deeper into the biological and genetic foundations of disease. At the same time we must recognize that major achievements in our lifetime will not come from those investments, but will come from changing the conditions under which people live and the conditions under which they receive care.
There we will see returns on investment within our lifetime. The investments we are making in precision medicine and genomics are for the future.
Financially struggling Cochise Regional Hospital, a 25-bed CAH in a town of 17,000, closed last month after the Centers for Medicare & Medicaid Services ended its provider agreement and shut off funding.
Douglas, AZ, a town of 17,000 souls nudged against the Mexican border, has become the latest small town in the United States to lose its hospital.
Financially struggling Cochise Regional Hospital, a 25-bed critical access hospital, was forced to shutter late last month after the Centers for Medicare & Medicaid Services ended its provider agreement and shut off funding.
CMS inspectors visited the hospital in March to address complaints about patient care. CMS provided a brief statement explaining the closure: "The most significant issue was the facility's failure to monitor an inpatient placed in a waiting room for 1.5 hours prior to transfer to another facility where the patient became unresponsive, had to have a breathing tube inserted, and ultimately died after being transferred to another hospital."
Harley Goldstein, is a Chicago-based attorney representing parent company People's Choice Hospital LLC, which bought the twice-bankrupt CRH in January, 2014. He says People's Choice was trying to correct the problems identified by state and federal inspectors when CMS withdrew the provider agreement. Read CMS's complaint, filed in US District Court for the District of Arizona.
"Cochise Regional Hospital aggressively sought not only to rectify the underlying issues, but also pursued a number of parallel tacks to avoid closing the hospital," Goldstein wrote in an email to response to my questions, "including filing of motion for a temporary restraining order in federal court to prevent Medicare and Medicaid from failing to provide coverage, contacting state and federal representatives, seeking remedies with the appropriate administrative agency, and negotiating extensively with the United States Attorney on behalf of the federal agencies to try to reinstate Medicare funding for going-forward patient care."
Despite those efforts, Goldstein says the hospital was denied a timely administrative appeal hearing and the U.S. Attorney's office refused to intervene.
"Accordingly, although the hospital kept its Emergency Department and related services open as long as was economically feasible without continued Medicare coverage in order to serve the local community while the hospital sought to resolve the Medicare coverage matter through negotiations (and in hopes that the U.S. Attorney or the politicians would intervene and convince the appropriate regulatory folks to change their minds so the community was not left deprived of critical-access medical services), such efforts were in vain," Goldstein says. "Without the reinstatement of Medicare coverage to Cochise Regional Hospital, the hospital lacked the funds to continue to operate, and closed its doors permanently."
The closure means that Douglas residents and emergency services will have to travel to Bisbee, AZ, 27 miles due west to access the nearest hospital. It also means the loss of 70 healthcare jobs and makes difficult the city's efforts to recruit new providers and businesses.
By some counts, Cochise Regional Hospital is the 56th rural hospital to close in the past five years, and unfortunately it may not be the last. Rural hospitals already operating on hair-thin margins took a severe hit during the Great Recession. These hospitals generally care for a patient mix that is older, sicker and less-affluent than in urban areas. In addition, inpatient services are declining, as are Medicare reimbursements. It's even worse for rural hospitals in states that have refused to expand their Medicaid programs under the Affordable Care Act, which Arizona reluctantly agreed to do in 2014.
Douglas Mayor Danny Ortega, Jr. calls CRH's closing a "tragedy" but not a surprise. CRH's financial and clinical problems were widely known and some sort of shake up was expected. Even before the closure, he says, many Douglas resident chose to get their care elsewhere.
Danny Ortega, Jr.
In the short term, the town is making due with a quick care center for non-emergency care, and transporting acute cases to Copper Queen Community Hospital in Bisbee. Ortega says the town will likely have to spend more for EMT overtime, and contract ambulance services with private companies.
"Long term, we had a meeting with the healthcare providers last week and there is some interest in building an emergency room here in Douglas by Copper Queen and there are a couple of organizations that are interested in bringing a hospital into town, Ortega says. "It is sad that we lost a hospital, but it is encouraging that there is interest in our community by these providers."
Ortega says city officials are still trying to gauge the economic fallout.
"We lost 70 jobs from that hospital, and we are trying to develop a new port of entry and the associated infrastructure and jobs," he says. "It is very difficult to recruit not only citizens to your community, but new industry when there is not a hospital in your town."
The $4 million stand-alone emergency department proposed for the town by Copper Queen would not be a 24-hour facility, and Ortega says his constituents believe that Douglas needs a new hospital.
"There are enough government jobs and people with insurance in town to support a hospital," he says. "Bisbee is a town of 5,300 and they have a 15-bed hospital. We are triple that population and we have nothing at this time."
So far, Ortega says, local providers have rallied to the cause. "They're not talking about leaving," he says. "Quite the opposite; they're asking what do we need to do to get a hospital here. Many of our physicians live in town and they know we need a hospital."
"I am hoping that in the end we will have something better than what we had," the mayor says. "The hospital was 75- 80-years old. It was antiquated. Some of the facilities were grandfathered in. The people of Douglas deserve a more modern facility."
Asked if he had any advice for other small town leaders who may confront a hospital closure, Ortega says: "Just keep fighting. Hopefully you'll get what you need."
